共 126 条
[1]
Jemal A(2007)Cancer statistics, 2007 CA Cancer J Clin 57 43-66
[2]
Siegel R(2005)Lymphoma: diagnosis, staging, natural history, and treatment strategies Semin Oncol 32 S4-10
[3]
Ward E(2006)Non-Hodgkin’s lymphoma: clinical practice guidelines in oncology J Natl Compr Canc Netw 4 258-310
[4]
Zinzani PL(1997)Fludarabine: an update of its pharmacology and use in the treatment of haematological malignancies Drugs 53 1005-37
[5]
Zelenetz AD(2003)Oral fludarabine Drugs 63 2317-23
[6]
Advani RH(2001)Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone Br J Haematol 114 800-9
[7]
Buadi F(2007)Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-KB signal pathway Leukemia 21 1044-9
[8]
Adkins JC(2002)Cellular and clinical pharmacology of fludarabine Clin Pharmacokinet 41 93-103
[9]
Peters DH(2002)The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study Cancer Invest 20 904-13
[10]
Markham A(1999)Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with “low-grade” non-Hodgkin’s lymphoma and B-cell chronic lymphocytic leukemia J Clin Oncol 17 1574-9